Anthony J. Bench - Concepedia

Author

Anthony J. Bench

Also Known As

A BENCH, A Bench, A J Bench, A. Bench, A. J. BENCH, A. J. Bench, A.J. Bench, Anthony Bench, Anthony J Bench, Anthony J. Bench

Publications

Citations

H-Index

Concepts

All Affiliations

University of Cambridge Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Wellcome Sanger Institute St Thomas' Hospital

About

Anthony J. Bench is an author at University of Cambridge specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	6.4K
2	Health Sciences	4	4	815
3	Natural Sciences	4	4	258
4	Engineering	1	1	28
5	Social Sciences	1	1	114

Anthony J. Bench

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders E. Joanna Baxter, Linda M. Scott, Peter J. Campbell, The Lancet Hematological MalignancyAcquired MutationReceptor Tyrosine KinaseHuman Myeloproliferative DisordersHematology	2005	3.4K
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders E. Joanna Baxter, Linda M. Scott, Peter J. Campbell, The Lancet Hematological MalignancyAcquired MutationReceptor Tyrosine KinaseHuman Myeloproliferative DisordersHematology	2005	1.1K
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study Peter J. Campbell, Linda M. Scott, Georgina Buck, The Lancet ThrombopoiesisImmunohematologyThrombosisEssential ThrombocythaemiaHematological Malignancy	2005	643
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort Philip Beer, Peter J. Campbell, Linda M. Scott, Blood	2008	419
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia Paul Sinclair, Elisabeth P. Nacheva, M. Leversha, Blood	2000	308
Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation Peter J. Campbell, E. Joanna Baxter, Philip Beer, Blood	2006	295
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype Alexandra Clipson, M Wang, Laurence de Leval, Leukemia Frequent Somatic ChangeLymphoid NeoplasiaDistinct GenotypeSomatic VariantGenetics	2014	175
Analysis of vertebrate SCL loci identifies conserved enhancers Berthold Göttgens, Linda Barton, James Gilbert, Nature Biotechnology BiologyNatural SciencesGeneticsGenomic MechanismGenetic Mechanism	2000	173
Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes Anthony J. Bench, Elisabeth P. Nacheva, Tracey L. Hood, Oncogene Hematological MalignancyChromatinCandidate GenesCommon Deleted RegionMedicine	2000	161
A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology Hongxiang Liu, Anthony J. Bench, Chris M. Bacon, British Journal of Haematology	2007	124

Page 1